Published 28th April 2020

CF (‘Carnall Farrar’), the healthcare management consultancy firm, is pleased to announce the appointment of Professor Donna Hall as a new advisor to the board.  Donna is currently an Integrated Care System advisor to NHSE, the Chair of the innovative think-tank the New Local Government Network, Chairs Bolton NHS Foundation Trust and is an appointed non-executive advisor to Birmingham City Council. Donna joins Chris Ham as current advisors to the board, who are helping shape the future of CF within the healthcare industry. 

Professor Hall was awarded a CBE in 2009 for innovation in public service and was Transformational Leader in the Northern Powerwomen Awards 2017. For eight years, Donna was the CEO of Wigan Council where she developed The Wigan Deal – which delivered 160 million savings and improved services and resident satisfaction.  

  Professor Donna Hall


She is a passionate feminist who championed “Believe in Her” and led a major equality change 
programme to ensure Wigan Council has a zero gender pay gap. Donna now holds the role of Chair for New Local Government Network and is the Chair of Bolton NHS Foundation Trust, as well as being an Integrated Care System advisor to NHS England.  She was appointed as an Honorary Professor of Politics at the University of Manchester in August 2019 and is a Non-Executive Adviser to Birmingham City Council. 

Anne Rainsberry, Managing Partner, commented: 

“We are thrilled that Donna has accepted this appointment, joining the CF family.  Donna brings with her a wealth of experience and expertise which will be invaluable as we grow and develop our offering. We are especially excited that Donna brings with her an in-depth knowledge of Integrated Care, which she is currently utilizing at NHSE as an Integrating Care System advisor.” 

Professor Hall said “I share CF’s commitment to delivering improved patient quality care.  I am very excited to work with Anne, Hannah and the rest of the CF family to help CF realise it’s ambitions.” 

Her appointment is effective 1 April 2020.